NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Clinical trials for NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can heated chemotherapy beat bladder cancer without surgery?
Disease control Not yet recruitingThis trial is testing a device that delivers heated chemotherapy directly into the bladder for people with non-muscle invasive bladder cancer. The goal is to see if the system is safe and works as intended. Participants will receive the treatment and be monitored for side effects…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: NA • Sponsor: Eight Medical International BV • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a simple urine test spare bladder cancer patients from chemotherapy?
Disease control Not yet recruitingThis trial asks whether some people with intermediate-risk bladder cancer can safely skip chemotherapy after having their tumor removed. Doctors will use a urine test before surgery to find patients whose tumors are unlikely to shed detectable signals. These patients will then be…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: NA • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a Bladder-Instilled biologic keep recurrent bladder cancer at bay?
Disease control Not yet recruitingThis early-phase trial is testing a new biologic drug, UGN-501, for people whose non-muscle invasive bladder cancer has returned after previous treatment. The drug is given directly into the bladder through a catheter once a week for six weeks, with possible quarterly maintenance…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: PHASE1 • Sponsor: UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New bladder cancer cocktail aims to spare patients from surgery
Disease control Not yet recruitingThis phase 2 trial tests whether a drug called N-803, combined with either BCG or gemcitabine, can treat intermediate-risk bladder cancer without needing surgery. About 20 adults with low-grade papillary tumors will receive the drugs directly into the bladder. The main goal is to…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Microscopic clues may forecast bladder Cancer's next move
Knowledge-focused Not yet recruitingThis study examines two microscopic details in bladder cancer tumors—how deep early cancer cells have invaded and whether small clusters of cells are present at the tumor's edge. Researchers will look at tissue samples from 100 patients to see if these features can predict if the…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC